Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein DBF4 homolog B (DBF4B) is a regulatory subunit that binds to and activates the CDC7 serine/threonine kinase, thereby controlling a key step in the initiation of DNA replication through phosphorylation of the MCM complex[3][1]. DBF4B is localized to the nucleus and is expressed in a cell cycle-dependent manner, particularly accumulating in S phase and being rapidly degraded thereafter[1]. The CDC7-DBF4B complex is required for S phase and mitotic progression, functioning by phosphorylating MCM2 and potentially other substrates, thus facilitating genome duplication and cell proliferation[3]. The activity and regulation of DBF4B is central to the propagation of genetic information and may be influential in cancer biology due to associations with cell division and transformation[2][3].
Drugs such as CDC7 kinase inhibitors block kinase activity, thereby inhibiting initiation of DNA replication and cell proliferation in contexts where DBF4B is the activating subunit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein DBF4 homolog B (DBF4B).